Introduction
Infantile choriocarcinoma is a rare and highly malignant germ-cell tumour arising from trophoblastic cells. Prognosis is poor if untreated. Rapid and accurate diagnosis is mandatory. b-Human chorionic gonadotrophin (b-HCG) levels in serum and urine are characteristically elevated because the tumour arises from trophoblastic cells. In the absence of a known maternal choriocarcinoma, the diagnosis is frequently incorrect because of the rarity of the lesion and the non-specific MRI findings. The liver is the most frequently involved organ in neonates. Infantile manifestations are believed to be metastases from a choriocarcinoma of the placenta [1] . The primary tumour can be microscopic in size and is usually missed on inspection of the placenta [1] . Choriocarcinoma has been described to occur after normal pregnancy (33%), abortion (35%) or hydatidiform mole pregnancy (32%) [2] . Newborn children present with a characteristic clinical picture consisting of a triad of anaemia, hepatomegaly and precocious puberty. Witzleben and Bruninga [3] described this as early as 1968 as 'infantile choriocarcinoma syndrome'. Few studies have described the imaging characteristics of choriocarcinoma [1, 2, 4, 5] . Frequently, the tumour is misdiagnosed as hepatoblastoma, hemangioendothelioma, mesenchymal hamartoma, metastatic neuroblastoma or undifferentiated hepatic sarcoma [2, 5, 6] . Early and accurate detection is, however, important for the child's and mother's survival. The goal of this case report is to present and discuss the value of dynamic gadoliniumenhanced MRI in infantile hepatic choriocarcinoma. . Physical examination revealed signs of precocious puberty with an enlarged penis, increased testicular volume and pubic hair. There was no organomegaly. The child was otherwise healthy and had no previous history of severe illness. Pregnancy and birth were unremarkable.
Abdominal ultrasonagraphy (US) revealed a solitary 6.8·5.0·4.4 cm, heterogeneous hypovascular mass within liver segments IVa and VIII. The remainder of the liver was normal. To improve tumour characterization, anatomical localization and to exclude additional lesions, dynamic contrast-enhanced MRI (1.5 T; Twin Speed, General Electric, Milwaukee, Wis., USA) was performed. Standard axial T1-weighted (T1) spin-echo (TR/TE 400/24, NEX 1, matrix 512·224, FOV 24·18 cm, slice thickness 6 mm, interslice gap 1.2 mm) and coronal T2-weighted (T2) fast spin-echo with fat suppression (TR/TE 8,333/110, NEX 2, matrix 320·224, FOV 26·20 cm, slice thickness 4 mm, interslice gap 0.8 mm) images were followed by a dynamic threedimensional T1 gradient-echo sequence (TR/TE 2.7/0.7, NEX 1, matrix 192·128, FOV 28·20 cm, slab thickness 64 mm, slice thickness reconstruction 1.5 mm).
A pre-contrast sequence was followed by three postcontrast acquisitions (arterial, porto-venous and delayed venous phase). Imaging was performed while the child was breathing spontaneously. Contrast medium (gadolinium 0.1 ml/kg body weight) was injected manually using a peripheral venous line. The well-circumscribed mass showed mixed T1-and T2-hypo-and hyperintense signal (Fig. 1) . Within the centre of the lesion a focal T1 hyperintensity was seen indicating haemorrhage. After injection of a gadolinium-based contrast medium, the mass showed strong peripheral enhancement in the arterial phase that persisted into the portal venous and delayed venous phases (Fig. 2) . The central areas showed minimal irregular enhancement without signs of filling-in on the delayed-phase scans (Fig. 3) . No additional focal lesions or enlarged lymph nodes were seen.
The lesion was initially interpreted as either a hepatoblastoma or hemangioendothelioma. Further laboratory tests were negative for a-fetoprotein and catecholamines. Liver function tests were within normal limits. Screening tests for hepatic infections were negative. The b-HCG level within the infant's serum was, however, distinctly elevated (>40,000 U/l). This laboratory finding in combination with the histological examination of a tumour biopsy established the diagnosis of solitary, infantile, malignant germ-cell tumour of the liver. Histology was compatible with choriocarcinoma with intense positivity for cytokeratin and b-HCG. Additional tumour work-up did not reveal any extrahepatic tumour spread. The child's mother has not yet been screened for b-HCG.
Neoadjuvant chemotherapy was administered for tumour reduction, followed by complete tumour resection. The child is currently in complete remission 7 months after diagnosis.
Discussion
Infantile hepatic choriocarcinoma is an extremely rare malignant tumour of the newborn and young infant. Fewer than 30 cases have been described. The clinical presentation is known as 'infantile choriocarcinoma Fig. 1 A Axial, T1 spin-echo image shows a heterogeneous lesion with focal hyperintensity indicating haemorrhage in liver segments IVa and VIII. B Coronal, T2 fast spin-echo image. The lesion is T2-hypo-and hyperintense and appears well marginated. No additional intrahepatic lesions are identified syndrome', characterized by anaemia, hepatomegaly and precocious puberty [3] . The development of choriocarcinoma in an infant is often believed to be a complication of placental choriocarcinoma that metastasizes to the infant. The primary placental tumour is rarely diagnosed because the primary tumour in the placenta is usually too small to be recognized on inspection. Consequently, the placenta is rarely examined histologically. Also in our case, the placenta was no longer available at the time of diagnosis.
Choriocarcinoma of the placenta has an incidence of 1 in 50,000 pregnancies [2] . Most infantile cases of choriocarcinoma occur between 5 weeks and 7 months of age or at term [1, 5] . Early dissemination and intractable disease require rapid diagnosis and treatment [1, 4] . Common sites of metastases for infantile hepatic choriocarcinoma are lung, kidney, brain and lymph nodes. The principal specific diagnostic test is the measurement of b-HCG levels in the serum and/or urine, which will be markedly elevated in the presence of the tumour. b-HCG is normally secreted by the placenta and by gonadal tumours containing trophoblastic cells [2, [7] [8] [9] . Elevated b-HCG levels cause the precocious puberty. The decline in serial serum b-HCG levels can be used to monitor treatment response. The tumour is usually highly susceptible to chemotherapy [10] .
Few studies have described the imaging findings of infantile hepatic choriocarcinoma [1, 2, 4, 5] . Although MRI is very sensitive for tumour detection and gives detailed anatomical information, the signal characteristics are non-specific. Choriocarcinoma usually has heterogeneous T1-and T2-signal intensity with large areas of central necrosis. T1-hyperintense haemorrhagic areas are frequently encountered, in addition to fluid-filled cysts with high-protein content that are T1-and T2-hyperintense. The pattern of contrast enhancement is also not very specific and does not improve diagnostic accuracy. Choriocarcinomas usually show strong and irregular peripheral enhancement without central tumoural enhancement. Consequently, in the absence of a known maternal choriocarcinoma, the tumour is usually misdiagnosed as hepatoblastoma, hemangioendothelioma, mesenchymal hamartoma, metastatic neuroblastoma or as undifferentiated hepatic sarcoma [2, [4] [5] [6] .
To the best of our knowledge, this report is the first to describe the enhancement pattern on dynamic gadolinium-enhanced MRI of an infantile hepatic choriocarcinoma. The tumour showed strong peripheral enhancement in the arterial phase that persisted into the delayed venous phase. There was no central filling-in of the tumour. On delayed-phase images obtained 5 min after contrast injection, there was no significant enhancement of the central tumour areas. This contrast pattern clearly differentiates the tumour from infantile hemangioendothelioma [6] . The absence of elevated a-fetoprotein and vanillylmandelic acid strongly militates against hepatoblastoma and neuroblastoma. Mesenchymal hamartoma usually shows more solid, contrastenhancing components. The contrast-enhancement pattern of the presented choriocarcinoma does not allow differentiation from undifferentiated hepatic sarcoma. The clinically observed signs of precocious puberty and In conclusion, this case shows that the MR signal intensities and dynamic contrast enhancement pattern are not characteristic for choriocarcinoma. The lack of filling-in on delayed sequences differentiates it from hemangioendothelioma that may look very similar on T1 and T2 MRI sequences. The specific diagnostic test is measurement of serum and/or urine b-HCG. Catecholamines and a-fetoprotein should be estimated to exclude neuroblastoma and hepatoblastoma, respectively. It should be remembered that infantile choriocarcinoma may later disseminate in the mother and she should also be screened for elevated b-HCG levels.
